Oncopeptides confirms blood-brain-barrier penetration in glioblastoma study

Oncopeptides AB confirmed blood-brain-barrier penetration based on data from the first patients in its glioblastoma Window-of-Opportunity study.

Detected & updated continuously · Source: Nebula